New digital channels deliver on the Company’s commitment to transparency and shareholder engagement

MAULDIN, SC / September 29, 2026 / Xcelerate Inc. (OTC: XCRT) today announced the launch of its official social media channels and a dedicated investor email registration program, advancing the digital engagement strategy outlined in the Company’s December 2025 year-end update.

The Company has established an official presence on X, YouTube, Instagram, and TikTok, where it will share progress updates on the Company’s AfiyaSasa Africa initiative, developments across its medical technology patent portfolio, insights from its leadership team, and other corporate milestones. Access to the Company’s information can be found at the following locations:

• X: @XcelerateUS
• YouTube: @Xcelerate.Global
• Instagram: @xcelerate.global
• TikTok: @xcelerate_inc

The channels are intended to give shareholders, partners, and the broader community timely, direct access to Company news as Xcelerate executes on its 2026 strategic priorities.

In addition, the Company has established a dedicated Investor Relations email at ir@xcelerate.global. Shareholders and interested investors are invited to register for investor email updates by writing to ir@xcelerate.global to receive Company announcements, press releases, and progress reports directly.

Michael O’Shea, Chief Executive Officer of Xcelerate, commented: “In our year-end update, we outlined a digital strategy to enhance transparency and shareholder engagement. We believe the launch of these channels and our dedicated investor email represents the execution of that commitment. As we advance the AfiyaSasa Africa initiative and continue to build our patent portfolio, we believe consistent, direct communication with our shareholders is essential, and we invite all shareholders to follow the Company and register for email updates.”

ABOUT XCELERATE INC.
Xcelerate is in the process of continuing to develop two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology.

For more information, visit www.xcelerate.global or contact us at 854-900-2020 or email info@xcelerate.global. To register for investor email updates, email ir@xcelerate.global.

SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth
strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward- looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ
materially from those projected in forward-looking statements resulting from various factors.

Xcelerate Inc., 110 Renaissance Circle, Mauldin, SC 29662,
Phone, +1 854-900-2020,
Email, info@xcelerate.global